NCT03638999View on ClinicalTrials.gov

NSAIDs Stent Study

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Ureteral Stent PlacementKidney Stone
Interventions
DRUG

Ketorolac Trometamol 30Mg/1mL Injection

Subjects in the intervention group will receive intravenous injection of 1 ml of Ketorlac 30 mg/ml prior to the start of the ureteroscopic procedure.

DRUG

Normal saline

Subjects in the control group will receive 1 ml of 0.9% injectable normal saline prior to the start of the ureteroscopic procedure.

Trial Locations (1)

63110

RECRUITING

Washington University, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER